13362-75-9Relevant academic research and scientific papers
Palladium- meta -terarylphosphine catalyst for the Mizoroki-Heck reaction of (hetero)aryl bromides and functional olefins
Tay, Daniel Weiliang,Jong, Howard,Lim, Yee Hwee,Wu, Wenqin,Chew, Xinying,Robins, Edward G.,Johannes, Charles W.
, p. 4054 - 4063 (2015/05/05)
The evolutionary meta-terarylphosphine ligand architecture of Cy?Phine was recently shown to be a key feature that imposed outstanding performance in palladium-catalyzed copper-free Sonogashira applications. Herein, the Pd-Cy?Phine combination has similar
Can Palladium Acetate Lose Its "saltiness"? Catalytic Activities of the Impurities in Palladium Acetate
Carole, William A.,Bradley, Jonathan,Sarwar, Misbah,Colacot, Thomas J.
supporting information, p. 5472 - 5475 (2015/11/18)
Commercially available palladium acetate often contains two major impurities, whose presence can impact the overall catalytic efficacy. This systematic study provides a comparison of the differences in catalytic activity of pure palladium acetate, Pd3(OAc)6, with the two impurities: Pd3(OAc)5(NO2) and polymeric [Pd(OAc)2]n in a variety of cross-coupling reactions. The solid state 13C NMR spectra of all three compounds in conjunction with DFT calculations confirm their reported geometries.
Heck cross-coupling of vinyl heteroaromatic compounds with aryl and heteroaryl halides using Pd(II) complex under phosphine-free conditions
Annapurna, Manne,Vishnuvardhan Reddy,Singh, Surya Prakash,Kantam, Mannepalli Lakshmi
, p. 10940 - 10945 (2014/01/06)
The palladium-catalyzed cross-coupling reaction of vinyl heteroaromatic compounds with aryl bromides and heteroaryl bromides is described using air and moisture stable N,N′,N″,O-tetrafunctional Pd catalyst under phosphine-free conditions. As a result a variety of trans-1,2-disubstituted vinyl heterocycles were obtained in high to good yields.
Utilities of olefin derivatives
-
Page/Page column 20; 30, (2008/06/13)
Compounds having an activity to enhance the expression of apoAI are provided. Compounds of formula (I): in which Ar1 and Ar2 are independently a phenyl, naphthyl, or monocyclic or bicyclic aromatic heterocyclic group, which may be optionally substituted; —X— is —N═CZ2-, —CY2═CZ2-, —CY2Y3—CHZ2-, —S—, —O—, or the like; Y1, Y2, Y3, Z1 and Z2 are independently a hydrogen, a halogen, a lower alkyl, a phenyl, or the like; Z1 and Z2 may be independently a linker group that may combine with Ar2 and Ar1 to form a condensed ring; m is 0 or 1, and n is 0 to 2; a prodrug thereof, a pharmaceutically acceptable salt or solvate of them; are disclosed.
